Oncternal Therapeutics Inc. buy melinda
Start price
14.04.17
/
50%
€27.91
Target price
05.05.17
€31.57
Performance (%)
4.54%
End price
05.05.17
€29.18
Summary
This prediction ended on 05.05.17 with a price of €29.18. The BUY prediction by melinda finished with a performance of 4.54%. melinda has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y | 3y |
---|---|---|---|---|
Oncternal Therapeutics Inc. | - | - | - | - |
iShares Core DAX® | -1.471% | 1.895% | 25.178% | 22.236% |
iShares Nasdaq 100 | -0.486% | 4.395% | 29.415% | 42.175% |
iShares Nikkei 225® | -2.115% | 2.450% | 20.561% | 6.454% |
iShares S&P 500 | 0.394% | 3.118% | 29.456% | 42.672% |
According to melinda what are the pros and cons of Oncternal Therapeutics Inc. for the foreseeable future?
Pros
Could be worthwhile Investment >10% per year
Cons
Comments by melinda for this prediction
In the thread Oncternal Therapeutics Inc. diskutieren
30/06/2017 Phase 2 Prelim Datenteil der Stufe 1 des Prozesses aufgrund 2Q 2017.
A $
(Vom Mitglied beendet)
Stopped prediction by melinda for Oncternal Therapeutics Inc.
Oncternal Therapeutics Inc.
Start price
Target price
Perf. (%)
€5.15
08.11.20
08.11.20
€5.00
08.11.21
08.11.21
-29.28%
09.11.21
09.11.21
Could be worthwhile Investment >10% per year
Oncternal Therapeutics Inc.
Start price
Target price
Perf. (%)
€9.16
16.11.18
16.11.18
€18.94
30.10.19
30.10.19
0.00%
30.10.19
30.10.19
Could be worthwhile Investment >10% per year
Oncternal Therapeutics Inc.
Start price
Target price
Perf. (%)
€11.24
22.09.18
22.09.18
€22.10
16.11.18
16.11.18
-18.54%
16.11.18
16.11.18
Could be worthwhile Investment >10% per year
Oncternal Therapeutics Inc.
Start price
Target price
Perf. (%)
€30.12
25.06.17
25.06.17
€34.73
29.06.17
29.06.17
20.34%
29.06.17
29.06.17
Could be worthwhile Investment >10% per year
Oncternal Therapeutics Inc.
Start price
Target price
Perf. (%)
€21.91
12.06.17
12.06.17
€21.47
12.06.17
12.06.17
12.97%
12.06.17
12.06.17
Could be worthwhile Investment >10% per year
Oncternal Therapeutics Inc.
Start price
Target price
Perf. (%)
€24.29
12.06.17
12.06.17
€23.80
12.06.17
12.06.17
12.97%
12.06.17
12.06.17
Could be worthwhile Investment >10% per year
Oncternal Therapeutics Inc.
Start price
Target price
Perf. (%)
€140.70
17.11.10
17.11.10
€210.00
17.05.11
17.05.11
104.98%
17.05.11
17.05.11
Could be worthwhile Investment >10% per year